Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A vs Topical Dihydromyricetin vs Combination for Periorbital Rejuvenation
TCTR20260616012Phase 4Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jun 2026
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A, dihydromyricetin in cutaneous aging, rhytides, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
botulinum toxin type Adihydromyricetin
03
Conditions
cutaneous agingrhytides
Beyond the preview
Go deeper on TCTR20260616012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260616012.